Related Experiment Video
Updated: Feb 28, 2026
07:38
Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
8.9K
Munchausen syndrome by proxy and pediatric nephrology
Cristina Bertulli1, Pierre Cochat2
1Pediatric department of spedali civili, University of Brescia, Piazzale Spedali Civili 1, 25100 Brescia, Italy.
Nephrologie & Therapeutique
|June 14, 2017
Summary
Munchausen syndrome by proxy, a fabrication of illness, frequently involves renal and urologic issues in children, affecting 25% of cases. Early recognition of this pediatric nephrology challenge is crucial to prevent harm.
Area of Science:
- Pediatric Nephrology
- Child Abuse and Neglect
Background:
- Munchausen syndrome by proxy (MSbP) involves fabricating illness in another person.
- Renal and urologic manifestations are significant in pediatric MSbP cases.
- MSbP presents a diagnostic challenge for healthcare professionals.
Purpose of the Study:
- To review pediatric nephrology cases associated with Munchausen syndrome by proxy.
- To categorize MSbP presentations based on primary clinical signs.
Main Methods:
- Retrospective review of pediatric nephrology cases.
- Analysis of cases diagnosed with Munchausen syndrome by proxy.
- Classification of cases by presenting renal or urologic signs.
Main Results:
- Approximately 25% of documented MSbP cases involve renal or urologic conditions.
- Identified common presenting signs in pediatric nephrology MSbP.
Conclusions:
- Pediatric renal and urologic issues are common indicators of Munchausen syndrome by proxy.
- Awareness of MSbP aids in early detection and mitigation of patient harm.
Related Concept Videos
01:24Nephrotic Syndrome I : Introduction
774
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
774
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
293
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
293
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
338
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
338
01:26Nephrotic Syndrome II : Assessment and Medical Management
281
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
281
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
392
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
392
01:24Chronic Kidney Disease II: Clinical Manifestations
801
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
801